The present invention provides glucopyranosyloxypyrazole derivatives
represented by the general formula: wherein R represents a hydrogen
atom, a lower alkyl group or a group forming a prodrug;.one of Q and T
represents a group represented by the general formula: (wherein P
represents a hydrogen atom or a group forming a prodrug), while the other
represents a lower alkyl group or a halo(lower alkyl) group; R.sup.2
represents a hydrogen atom, a lower alkyl group, a lower alkoxy group, a
lower alkylthio group, a halo (lower alkyl) group or a halogen atom; and
with the proviso that P does not represent a hydrogen atom when R
represents a hydrogen atom or a lower alkyl group, or pharmaceutically
acceptable salts thereof, which exert an inhibitory activity in human
SGLT2 and have an improved oral absorption, and therefore are useful as
agents for the prevention or treatment of a disease associated with
hyperglycemia such as diabetes, diabetic complications or obesity, and
pharmaceutically acceptable salts thereof, and pharmaceutical uses
thereof.